🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquarePet photos thread v2 — what worked for you? Page 3

Pet photos thread v2 — what worked for you?

Dr.MetabolicMD Sun, Dec 29, 2024 at 2:39 AM 15 replies 1,818 viewsPage 3 of 3
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Jan 2, 2025 at 11:27 PM#11
PedsEndoPhilly said:
Propensity score matching studies and the trial evidence: when RCTs aren't available for a specific question, propensity score-matched observational…

True, with the qualification that this is a self-selected group. The people for whom it did not work post less, and that shapes everything we think we know.

34 9jennifer_SEA, tyler_CSCS, VanRx_Mike and 31 others
Reply Quote Save Share Report
paige_pharma
Member
289
1,234
Sep 2024
Omaha, NE
Jan 3, 2025 at 10:50 AM#12
tyler_CSCS said:
Forest plot interpretation for the the trial evidence meta-analysis: when reading the pooled estimate, pay attention to: Point estimate (HR/RR/OR) —…

Bookmarking. The distinction being drawn above is the one nobody else makes. Adding it to my notes with a link back to this thread.

33 8Dr.SurgeonPGH, rachel_ABQ, traveltech_sara and 30 others
Reply Quote Save Share Report
HealthEcon_DC
Member
567
3,456
Apr 2024
Washington, DC
Jan 3, 2025 at 10:13 PM#13
PedsEndoPhilly said:
Propensity score matching studies and the trial evidence: when RCTs aren't available for a specific question, propensity score-matched observational…

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

Last edited: Jan 4, 2025 at 12:13 AM
32 7KevinCompounds, TirzTom, TrialTracker_MD and 29 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
dave_SLC
Member
345
1,567
Aug 2024
Salt Lake City, UT
Jan 4, 2025 at 9:36 AM#14

One concrete data point for the thread. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

31 6FranDenver, Dr.BariatricHTX, LindaRN_retired and 28 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jan 4, 2025 at 8:59 PM#15

Moderator note: the sourcing question belongs in the vendor section and has been split out. Thread quality here is what the rules are for. Keep it up.

Last edited: Jan 5, 2025 at 12:59 AM
30 5PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 27 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register